Don't Be Surprised to See Buprenorphine for Chronic Pain
November 2021
You'll see growing interest in buprenorphine (Belbuca, Butrans, etc) for chronic pain...partly to reduce opioid risks.
Buprenorphine is a partial agonist at mu-opioid receptors...and an ANTagonist at other opioid receptors.
That's why it seems to hit a ceiling that limits respiratory depression...may cause less euphoria compared to full opioid agonists (morphine, etc)...and may have less potential for misuse.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote